EXANE DERIVATIVES - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q1 2022$430,000
-12.4%
300.0%0.00%
Q3 2021$491,000
-2.4%
300.0%0.00%
Q2 2021$503,000
-8.2%
300.0%0.00%
Q1 2021$548,000
+0.4%
300.0%0.00%
Q4 2020$546,000
+2.1%
300.0%0.00%
Q3 2020$535,000
-0.6%
300.0%0.00%
Q2 2020$538,000
+18.2%
300.0%0.00%
Q1 2020$455,000
-24.2%
300.0%0.00%
Q4 2019$600,000
+16.3%
300.0%0.00%
Q3 2019$516,000
-2.8%
300.0%0.00%
Q2 2019$531,000
-13.1%
300.0%0.00%
Q1 2019$611,000300.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Bartlett & Co. LLC 20,781$2960.01%
Valued Wealth Advisors LLC 231$3,5740.00%
BALDWIN BROTHERS LLC/MA 2,035$29,0390.00%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders